(Q37869905)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21526898%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

review article

1 reference

title

The rise of metal radionuclides in medical imaging: copper-64, zirconium-89 and yttrium-86 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21526898%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

1 reference

1 reference

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21526898%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Oluwatayo F Ikotun

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21526898%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

1 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21526898%20AND%20SRC:MED&resulttype=core&format=json

Future Medicinal Chemistry

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21526898%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21526898%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21526898%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

599-621

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21526898%20AND%20SRC:MED&resulttype=core&format=json

Production and separation of non-carrier-added 86Y from enriched 86Sr targets.

30 January 2020

cites work

1 reference

Production and applications of copper-64 radiopharmaceuticals

21 January 2018

1 reference

Efficient production of high specific activity 64Cu using a biomedical cyclotron

21 January 2018

1 reference

Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease

21 January 2018

1 reference

Preparation of high specific activity (86)Y using a small biomedical cyclotron

21 January 2018

1 reference

Copper chelation chemistry and its role in copper radiopharmaceuticals.

21 January 2018

1 reference

Standardized methods for the production of high specific-activity zirconium-89.

21 January 2018

1 reference

Radioimmunoimaging with longer-lived positron-emitting radionuclides: potentials and challenges.

21 January 2018

1 reference

Preparation and evaluation of (89)Zr-Zevalin for monitoring of (90)Y-Zevalin biodistribution with positron emission tomography.

21 January 2018

1 reference

Copper chelates as probes of biological systems: stable copper complexes with a macrocyclic bifunctional chelating agent.

21 January 2018

1 reference

Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET).

21 January 2018

1 reference

True radiotracers: Cu-64 targeting vectors based upon bombesin peptide.

21 January 2018

1 reference

Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research

21 January 2018

1 reference

Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy

21 January 2018

1 reference

An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix

21 January 2018

1 reference

In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM

21 January 2018

1 reference

Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report

21 January 2018

1 reference

Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia

21 January 2018

1 reference

Positron Emission Tomography Imaging of Hypoxia

21 January 2018

1 reference

Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy

21 January 2018

1 reference

Bis(thiosemicarbazonato) Cu-64 complexes for positron emission tomography imaging of Alzheimer's disease.

21 January 2018

1 reference

A copper radiopharmaceutical for diagnostic imaging of Alzheimer's disease: a bis(thiosemicarbazonato)copper(II) complex that binds to amyloid-beta plaques.

21 January 2018

1 reference

The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors

21 January 2018

1 reference

Comparison of four 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model: evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy.

21 January 2018

1 reference

Validation of a novel CHX-A'' derivative suitable for peptide conjugation: small animal PET/CT imaging using yttrium-86-CHX-A''-octreotide.

21 January 2018

1 reference

Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast

21 January 2018

1 reference

MicroPET imaging of breast cancer using radiolabeled bombesin analogs targeting the gastrin-releasing peptide receptor

21 January 2018

1 reference

MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue.

21 January 2018

1 reference

In vitro and in vivo evaluation of 64Cu-labeled DOTA-linker-bombesin(7-14) analogues containing different amino acid linker moieties

21 January 2018

1 reference

Comparative in vitro and in vivo evaluation of two 64Cu-labeled bombesin analogs in a mouse model of human prostate adenocarcinoma.

21 January 2018

1 reference

[64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues

21 January 2018

1 reference

In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems

21 January 2018

1 reference

The role of integrins in tumor angiogenesis

21 January 2018

1 reference

RGD and other recognition sequences for integrins

21 January 2018

1 reference

(64)Cu-labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity

21 January 2018

1 reference

MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides

21 January 2018

1 reference

Targeting the alphavbeta3 integrin for small-animal PET/CT of osteolytic bone metastases

21 January 2018

1 reference

HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibition

21 January 2018

1 reference

Melanotropic peptide receptors: membrane markers of human melanoma cells

21 January 2018

1 reference

Melanotropin receptors demonstrated in situ in human melanoma

21 January 2018

1 reference

Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH.

21 January 2018

1 reference

alpha -melanocyte-stimulating hormone is a novel regulator of bone

21 January 2018

1 reference

Imaging of melanoma using 64Cu- and 86Y-DOTA-ReCCMSH(Arg11), a cyclized peptide analogue of alpha-MSH.

21 January 2018

1 reference

64Cu-labeled affibody molecules for imaging of HER2 expressing tumors

21 January 2018

1 reference

Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled affibody protein

21 January 2018

1 reference

Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours: comparison of (86)Y-DOTATOC and (111)In-DTPA-octreotide

21 January 2018

1 reference

86Y-DOTA0)-D-Phe1-Tyr3-octreotide (SMT487)--a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion

21 January 2018

1 reference

Monoclonal antibodies as innovative therapeutics

21 January 2018

1 reference

Immuno-positron emission tomography: shedding light on clinical antibody therapy

21 January 2018

1 reference

Antibodies for molecular imaging of cancer

21 January 2018

1 reference

Numerical selection of optimal tumor imaging agents with application to engineered antibodies

21 January 2018

1 reference

Positive progress in immunoPET--not just a coincidence

21 January 2018

1 reference

Therapeutic antibodies for human diseases at the dawn of the twenty-first century

21 January 2018

1 reference

Monoclonal antibodies as reversible equilibrium carriers of radiopharmaceuticals

21 January 2018

1 reference

Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods

21 January 2018

1 reference

Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody

21 January 2018

1 reference

Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors.

21 January 2018

1 reference

PET of EGFR antibody distribution in head and neck squamous cell carcinoma models

21 January 2018

1 reference

PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen.

21 January 2018

1 reference

Monitoring therapeutic response of human ovarian cancer to 17-DMAG by noninvasive PET imaging with (64)Cu-DOTA-trastuzumab

21 January 2018

1 reference

High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment

21 January 2018

1 reference

A versatile bifunctional chelate for radiolabeling humanized anti-CEA antibody with In-111 and Cu-64 at either thiol or amino groups: PET imaging of CEA-positive tumors with whole antibodies

21 January 2018

1 reference

PET imaging of HER1-expressing xenografts in mice with 86Y-CHX-A''-DTPA-cetuximab.

21 January 2018

1 reference

Preparation, biological evaluation, and pharmacokinetics of the human anti-HER1 monoclonal antibody panitumumab labeled with 86Y for quantitative PET of carcinoma

21 January 2018

1 reference

In vivo biodistribution, PET imaging, and tumor accumulation of 86Y- and 111In-antimindin/RG-1, engineered antibody fragments in LNCaP tumor-bearing nude mice.

21 January 2018

1 reference

Disparity between in vivo EGFR expression and 89Zr-labeled cetuximab uptake assessed with PET.

21 January 2018

1 reference

89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo.

21 January 2018

1 reference

In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft.

21 January 2018

1 reference

Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.

21 January 2018

1 reference

Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients.

21 January 2018

1 reference

Biodistribution of 89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer

21 January 2018

1 reference

In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent

21 January 2018

1 reference

Nanoparticles for molecular imaging--an overview.

21 January 2018

1 reference

Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots

21 January 2018

1 reference

Quantum dots for live cells, in vivo imaging, and diagnostics

21 January 2018

1 reference

Semiconductor nanocrystals as fluorescent biological labels

21 January 2018

1 reference

Quantum dot bioconjugates for ultrasensitive nonisotopic detection.

21 January 2018

1 reference

Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature

21 January 2018

1 reference

Quantum dot bioconjugates for imaging, labelling and sensing

21 January 2018

1 reference

Gadolinium-rhodamine nanoparticles for cell labeling and tracking via magnetic resonance and optical imaging

21 January 2018

1 reference

Annexin A5-functionalized bimodal lipid-based contrast agents for the detection of apoptosis.

21 January 2018

1 reference

Self-assembled hybrid nanoparticles for cancer-specific multimodal imaging

21 January 2018

1 reference

Current state and future applications of active targeting in malignancies using superparamagnetic iron oxide nanoparticles

21 January 2018

1 reference

Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes

21 January 2018

1 reference

'Two is better than one'--probes for dual-modality molecular imaging

21 January 2018

1 reference

Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis.

21 January 2018

1 reference

Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumab

21 January 2018

1 reference

Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging

21 January 2018

1 reference

Molecular Imaging of Hypoxia

21 January 2018

1 reference

Antibodies against metal chelates

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.4155/FMC.11.14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21526898%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference